デフォルト表紙
市場調査レポート
商品コード
1593760

酵素市場:製品タイプ別、タイプ別、由来別、反応タイプ別、用途別、地域別、機会、予測、2017年~2031年

Enzymes Market Assessment, By Product Type, By Type, By Source, By Reaction Type, By Application, By Region, Opportunities and Forecast, 2017-2031F


出版日
ページ情報
英文 229 Pages
納期
3~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
酵素市場:製品タイプ別、タイプ別、由来別、反応タイプ別、用途別、地域別、機会、予測、2017年~2031年
出版日: 2024年11月20日
発行: Market Xcel - Markets and Data
ページ情報: 英文 229 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の酵素の市場規模は、2024年~2031年の予測期間中に6.55%のCAGRで拡大し、2023年の120億6,000万米ドルから2031年には200億3,000万米ドルに成長すると予測されています。同市場の成長を支えているのは、世界の医薬品・ヘルスケア分野の拡大、先端技術の台頭、環境に優しい技術の利用拡大です。市場の主要参入企業による生産設備の拡張に向けた投資の増加は、市場シェアの拡大を支援し、市場に有利な成長機会を提供すると期待されています。2024年7月、酵素の力を借りて食品加工・製造に革新的なソリューションを提供することで知られるAmano Enzyme Inc.は、米国イリノイ州での製造拠点の拡張を祝っています。建設は2025年4月までに完了する予定で、革新的な新酵素を提供する上で同社をサポートするものと期待されています。

さらに、新規酵素の開発を強化するための共同研究の増加も市場の拡大を支えています。2024年8月、Twist Bioscience CorporationとbitBiome, Inc.はトランスアミナーゼ酵素スクリーニングキットの発売を発表しました。トランスアミナーゼは、製薬産業に不可欠なキラルアミンを合成するための選択肢として登場し、従来の合成に代わるグリーンな選択肢を提供しています。このキットは、製薬会社や研究所が医薬品有効成分の合成に使用できるユニークなトランスアミナーゼを特徴としています。このような共同研究は、さまざまな産業向けの革新的なソリューションの提供を強化すると期待されています。

さらに、焼き菓子の消費の増加は、酵素の世界の需要を強化しました。米国製パン協会の推計によると、製パン産業は米国で1,860億米ドルを超える経済効果をもたらしています。酵素と酵母は焼き菓子の製造に重要な役割を果たしており、アミラーゼは製パン工程で重要な役割を果たし、プロテアーゼはグルテンの物理的特性に大きな影響を及ぼし、ヘミセルラーゼは小麦粉の水分結合能を破壊する能力を持ち、生地の軟化を引き起こします。このように、焼き菓子の消費の拡大は、世界の酵素市場に有利な成長機会をもたらすと期待されています。

当レポートでは、世界の酵素市場について調査し、市場の概要とともに、製品タイプ別、タイプ別、由来別、反応タイプ別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の酵素市場の見通し、2017年~2031年

  • 市場規模の分析と予測
  • 市場シェア分析と予測
  • 市場マップ分析、2023年
    • 製品タイプ別
    • タイプ別
    • 由来別
    • 反応タイプ別
    • 用途別
    • 地域別

第5章 北米の酵素市場の見通し、2017年~2031年

第6章 欧州の酵素市場の見通し、2017年~2031年

第7章 アジア太平洋の酵素市場の見通し、2017年~2031年

第8章 南米の酵素市場の見通し、2017年~2031年

第9章 中東・アフリカの酵素市場の見通し、2017年~2031年

第10章 需要供給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

第18章 特許の情勢

第19章 ケーススタディ

第20章 競合情勢

  • 市場リーダートップ5の競合マトリックス
  • 参入企業トップ5のSWOT分析
  • 市場参入企業トップ10の情勢
    • BASF SE
    • DuPont de Nemours, Inc.
    • F. Hoffmann-La Roche Ltd
    • Novonesis Group (Novozymes A/S)
    • DSM-Firmenich AG
    • Lesaffre group
    • Codexis, Inc.
    • Advanced Enzyme Technologies Limited
    • Kerry Group
    • Amano Enzyme Inc.

第21章 戦略的提言

第22章 お問い合わせと免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 3. Global Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 5. Global Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 6. Global Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Enzymes Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 10. North America Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 11. North America Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 12. North America Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 13. North America Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 14. North America Enzymes Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 17. United States Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 18. United States Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 19. United States Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 20. United States Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 21. Canada Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 23. Canada Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 24. Canada Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 25. Canada Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 26. Canada Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 29. Mexico Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 30. Mexico Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 31. Mexico Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 32. Mexico Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 33. Europe Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 35. Europe Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 36. Europe Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 37. Europe Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 38. Europe Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 39. Europe Enzymes Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 42. Germany Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 43. Germany Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 44. Germany Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 45. Germany Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 46. France Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 48. France Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 49. France Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 50. France Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 51. France Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 52. Italy Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 54. Italy Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 55. Italy Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 56. Italy Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 57. Italy Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 58. United Kingdom Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 60. United Kingdom Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 61. United Kingdom Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 62. United Kingdom Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 63. United Kingdom Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 64. Russia Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 66. Russia Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 67. Russia Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 68. Russia Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 69. Russia Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 70. Netherlands Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Netherlands Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 73. Netherlands Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 74. Netherlands Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 75. Netherlands Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 76. Spain Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 78. Spain Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 79. Spain Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 80. Spain Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 81. Spain Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 82. Turkey Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 84. Turkey Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 85. Turkey Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 86. Turkey Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 87. Turkey Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 88. Poland Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 90. Poland Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 91. Poland Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 92. Poland Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 93. Poland Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 94. South America Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 96. South America Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 97. South America Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 98. South America Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 99. South America Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 100. South America Enzymes Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 103. Brazil Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 104. Brazil Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 105. Brazil Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 106. Brazil Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 107. Argentina Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 109. Argentina Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 110. Argentina Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 111. Argentina Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 112. Argentina Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 113. Asia-Pacific Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 115. Asia-Pacific Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 116. Asia-Pacific Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 117. Asia-Pacific Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 118. Asia-Pacific Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 119. Asia-Pacific Enzymes Market Share (%), By Country, 2017-2031F
  • Figure 120. India Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 122. India Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 123. India Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 124. India Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 125. India Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 126. China Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 128. China Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 129. China Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 130. China Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 131. China Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 132. Japan Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Japan Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 135. Japan Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 136. Japan Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 137. Japan Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 138. Australia Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 140. Australia Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 141. Australia Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 142. Australia Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 143. Australia Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 144. Vietnam Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 146. Vietnam Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 147. Vietnam Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 148. Vietnam Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 149. Vietnam Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 150. South Korea Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 152. South Korea Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 153. South Korea Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 154. South Korea Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 155. South Korea Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 156. Indonesia Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 158. Indonesia Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 159. Indonesia Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 160. Indonesia Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 161. Indonesia Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 162. Philippines Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 164. Philippines Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 165. Philippines Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 166. Philippines Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 167. Philippines Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 168. Middle East & Africa Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 170. Middle East & Africa Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 171. Middle East & Africa Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 172. Middle East & Africa Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 173. Middle East & Africa Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 174. Middle East & Africa Enzymes Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 177. Saudi Arabia Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 178. Saudi Arabia Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 179. Saudi Arabia Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 180. Saudi Arabia Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 181. UAE Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 183. UAE Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 184. UAE Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 185. UAE Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 186. UAE Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 187. South Africa Enzymes Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Enzymes Market Share (%), By Product Type, 2017-2031F
  • Figure 189. South Africa Enzymes Market Share (%), By Type, 2017-2031F
  • Figure 190. South Africa Enzymes Market Share (%), By Source, 2017-2031F
  • Figure 191. South Africa Enzymes Market Share (%), By Reaction Type, 2017-2031F
  • Figure 192. South Africa Enzymes Market Share (%), By Application, 2017-2031F
  • Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By Reaction Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX12272

Global enzymes market is projected to witness a CAGR of 6.55% during the forecast period 2024-2031, growing from USD 12.06 billion in 2023 to USD 20.03 billion in 2031. The market's growth is supported by expanding the global pharmaceutical and healthcare sectors, emerging advanced technologies, and increasing utilization of eco-friendly technologies. The rising investments by the market's key players towards the expansion of their production facilities are expected to aid them in expanding their market share and provide lucrative growth opportunities for the market. In July 2024, Amano Enzyme Inc., known for providing innovative solutions for food processing and manufacturing with the help of enzymes, celebrated the expansion of its manufacturing site in Illinois, United States. The construction is expected to be completed by April 2025 and is anticipated to support the company in delivering innovative new enzymes.

Furthermore, rising collaborations to augment the development of novel enzymes are also supporting the market's expansion. In August 2024, Twist Bioscience Corporation and bitBiome, Inc. announced the launch of their Transaminase Enzyme Screening Kit. Transaminase has emerged as an option for synthesizing chiral amines, which is essential for the pharmaceutical industry and offers a green alternative to conventional synthesis. The kit features unique transaminases that pharma companies and laboratories can use to synthesize active pharmaceutical ingredients. Such collaborations are expected to bolster the availability of innovative solutions for different industries.

Additionally, the increasing consumption of baked goods bolstered the global demand for enzymes. As per the estimates of the American Bakers Association, the baking industry has an economic impact of over USD 186 billion in the United States. Enzymes and yeasts play a significant role in the production of baked goods, with amylases playing a crucial role in the bread-making process, proteases having large effects on physical gluten properties, and hemicellulases holding the capacity to destroy the water binding capacity of wheat flour, causing softening of dough. Thus, the growing consumption of baked goods is expected to provide lucrative growth opportunities to the global enzymes market.

Integration of AI Provides Growth Opportunities

Startups across the globe are receiving funding to advance enzyme design with the help of generative (artificial intelligence) AI. In August 2024, BIOMATTER INC. secured approximately USD 7 million (€6.5M) in funding for their innovative approach to designing enzymes from scratch, allowing them to go beyond the limitations of natural enzymes. They can also tailor enzymes for different sectors, reducing the development time from years to weeks.

Meanwhile, the development of AI models for producing sequences that support the production of functional enzymes with the required characteristics for different applications is also expected to influence the global enzymes market's expansion positively. In June 2024, Basecamp Research and Ferruz Laboratory at the Institute of Molecular Biology of Barcelona announced the release of ZymCTRL in partnership. The ChatGPT-like tool is used to generate new sequences from scratch with the help of an enzyme identification code that specifies the desired activity. ZymCTRL also offers cost-effective and rapid design capabilities for generating artificial enzymes and requires no seed sequence as opposed to other large language models.

Rising Collaborations Among Biotech Companies Support Market Expansion

The rising efforts of the leading biotech companies to bolster the production of next-generation enzymes are boosting the global enzymes market size. In April 2024, Ginkgo Bioworks and Prozomix Limited announced a new partnership to build out the production of next-gen enzyme plates for manufacturing active pharmaceutical ingredients. The partnership aims to leverage Prozomix's deep experience in manufacturing enzyme plates and existing enzyme libraries, as well as Ginkgo's industry-leading artificial intelligence/machine learning (AI/ML) models and enzyme services. This collaboration will also support the entry of Prozomix in Ginkgo's Technology Network, bring together a wide range of partners that span manufacturing, biologics, genetic medicines, and AI, and aim to integrate their capabilities for providing customers with successful research and development outcomes and end-to-end solutions. Ginkgo's customers will also have access to Prozomix's contract manufacturing services, such as enzyme samples. Such partnerships are expected to boost the production of next-generation enzymes and provide lucrative growth opportunities to the enzyme market.

Industrial Enzymes Account for Significant Market Share

The growth of the segment can be attributed to the rapid expansion of various industries and increasing investments in industrial enzymes. Industrial enzymes act as biocatalysts in several traditional chemical processes to enhance process efficiency and sustainability and find applications in sectors including textiles, feed, and detergents, among others. In August 2024, Lallemand Inc. invested in LIVZYM BIOTECHNOLOGY as part of its strategic collaboration in the industrial enzyme segment. LIVZYM is the first producer of industrial enzymes based in Turkey, allowing the company to serve customers across the Middle East and Africa, Europe, and Asia. The strategic investment from Lallemand is expected to provide LIVZYM with a significant opportunity to advance alternative protein technologies and sustainability. Additionally, the utilization of industrial enzymes by the detergents industry is also increasing, with amylases, lipases, and proteases being added to laundry detergents to make them more effective at lower temperatures and improve stain removal.

North America Holds the Major Market Share

The rapid expansion of healthcare, pharmaceutical, food and beverage, and agriculture and livestock sectors in the region augments the growth of the North America enzymes market. The strong presence of key players in the United States also provides lucrative growth opportunities for the market. In January 2023, BASF SE and Cargill announced expanded cooperation to add the United States to their existing feed enzymes distribution and development agreement. The collaboration aided the companies in increasing the accessibility to animal feed among the business owners while ensuring the availability of high-performance enzyme solutions that have been shown to improve sustainability, reduce nutrient waste, and improve feed efficiency.

Meanwhile, the market is expected to witness significant growth in the Asia-Pacific region over the forecast period. This growth can be attributed to the rapid expansion of the food and beverage industry, growing requirements for processed foods, and rising demand for pharmaceuticals. As per the estimates of the India Brand Equity Foundation (IBEF), the domestic pharmaceutical industry is expected to reach USD 57 billion by FY2025. This growth is expected to propel the requirement for enzymes in the region as they are used directly for therapeutic applications as a drug as well as tools in manufacturing active pharmaceutical ingredients.

Future Market Scenario (2024-2031F)

As per the global enzymes market analysis, the market is expected to witness significant growth in the coming years due to the rising requirement for enzymes to meet the growing demand from pharmaceutical, food and beverage, and healthcare sectors, among others, in various regions across the globe. According to the estimates of the IBEF, the total market size of the pharma industry in India is expected to reach USD 450 billion by 2047. Such expansions are expected to bolster the market's demand and support its expansion in the Asia-Pacific region. Rising income levels and rapid population expansion are expected to increase enzyme requirements in the coming years. According to estimates from the United Nations, the global population is expected to grow to 9.7 billion by 2050. The expansion of the population is also expected to propel the reliance on the agriculture industry to meet the growing food demand, thus augmenting the requirement for soil treatment and positively influencing the market's expansion. Soil enzymes aid in increasing the rate of reaction at which plant residues start decomposing and releasing the available nutrients.

Key Players Landscape and Outlook

The key players in the market are increasingly engaging in mergers and acquisitions and collaboration activities to focus on their growth and expand their product portfolio. In October 2024, Codexis, Inc. announced that they have entered into a non-exclusive commercial and manufacturing licensing agreement for multiple enzymes in their life science enzyme portfolio with Alphazyme, LLC. The agreement involves the licenses for HiRev Isothermal Polymerase, HiTemp Reverse Transcriptase, and HiFi DNA Polymerase, among other enzymes. The transaction will enable Codexis, Inc., to focus on its strategic priorities as well as its near-term commercial opportunities. The agreement also marks another transaction in the company's strategy to divest their non-core assets to focus on the growth of their Enzyme Catalyzed Oligonucleotide (ECO) Synthesis manufacturing platform and the pharmaceutical manufacturing business.

In December 2023, Kerry Group announced that they had agreed to acquire Novozymes A/S and Chr. Hansen A/S's lactase enzyme business for approximately USD 162 million (€150 million). The European Commission cleared Hansen A/S and Novozymes A/S upon full compliance with the commitments. With the acquisition of the lactase enzyme business, Kerry Group will have access to technology that aids them in creating reduced-sugar and lactose-free dairy products.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Enzymes Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Industrial Enzymes
      • 4.2.1.2. Specialty Enzymes
    • 4.2.2. By Type
      • 4.2.2.1. Carbohydrase
      • 4.2.2.2. Proteases
      • 4.2.2.3. Lipases
      • 4.2.2.4. Polymerases and Nucleases
      • 4.2.2.5. Others
    • 4.2.3. By Source
      • 4.2.3.1. Microorganisms
      • 4.2.3.2. Plants
      • 4.2.3.3. Animals
    • 4.2.4. By Reaction Type
      • 4.2.4.1. Hydrolase
      • 4.2.4.2. Oxidoreductase
      • 4.2.4.3. Transferase
      • 4.2.4.4. Lyase
      • 4.2.4.5. Others
    • 4.2.5. By Application
      • 4.2.5.1. Pharmaceuticals and Biotechnology Companies
      • 4.2.5.2. Research
      • 4.2.5.3. Diagnostics
      • 4.2.5.4. Food and Beverages
      • 4.2.5.5. Soil Treatment
      • 4.2.5.6. Oil Treatment
      • 4.2.5.7. Wastewater Treatment
      • 4.2.5.8. Detergents
      • 4.2.5.9. Feed
      • 4.2.5.10. Textile
      • 4.2.5.11. Others
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia-Pacific
      • 4.2.6.4. South America
      • 4.2.6.5. Middle East and Africa
    • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product Type
    • 4.3.2. By Type
    • 4.3.3. By Source
    • 4.3.4. By Reaction Type
    • 4.3.5. By Application
    • 4.3.6. By Region

5. North America Enzymes Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. Industrial Enzymes
      • 5.2.1.2. Specialty Enzymes
    • 5.2.2. By Type
      • 5.2.2.1. Carbohydrase
      • 5.2.2.2. Proteases
      • 5.2.2.3. Lipases
      • 5.2.2.4. Polymerases and Nucleases
      • 5.2.2.5. Others
    • 5.2.3. By Source
      • 5.2.3.1. Microorganisms
      • 5.2.3.2. Plants
      • 5.2.3.3. Animals
    • 5.2.4. By Reaction Type
      • 5.2.4.1. Hydrolase
      • 5.2.4.2. Oxidoreductase
      • 5.2.4.3. Transferase
      • 5.2.4.4. Lyase
      • 5.2.4.5. Others
    • 5.2.5. By Application
      • 5.2.5.1. Pharmaceuticals and Biotechnology Companies
      • 5.2.5.2. Research
      • 5.2.5.3. Diagnostics
      • 5.2.5.4. Food and Beverages
      • 5.2.5.5. Soil Treatment
      • 5.2.5.6. Oil Treatment
      • 5.2.5.7. Wastewater Treatment
      • 5.2.5.8. Detergents
      • 5.2.5.9. Feed
      • 5.2.5.10. Textile
      • 5.2.5.11. Others
    • 5.2.6. By Country Share
      • 5.2.6.1. United States
      • 5.2.6.2. Canada
      • 5.2.6.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Enzymes Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product Type
          • 5.3.1.2.1.1. Industrial Enzymes
          • 5.3.1.2.1.2. Specialty Enzymes
        • 5.3.1.2.2. By Type
          • 5.3.1.2.2.1. Carbohydrase
          • 5.3.1.2.2.2. Proteases
          • 5.3.1.2.2.3. Lipases
          • 5.3.1.2.2.4. Polymerases and Nucleases
          • 5.3.1.2.2.5. Others
        • 5.3.1.2.3. By Source
          • 5.3.1.2.3.1. Microorganisms
          • 5.3.1.2.3.2. Plants
          • 5.3.1.2.3.3. Animals
        • 5.3.1.2.4. By Reaction Type
          • 5.3.1.2.4.1. Hydrolase
          • 5.3.1.2.4.2. Oxidoreductase
          • 5.3.1.2.4.3. Transferase
          • 5.3.1.2.4.4. Lyase
          • 5.3.1.2.4.5. Others
        • 5.3.1.2.5. By Application
          • 5.3.1.2.5.1. Pharmaceuticals and Biotechnology Companies
          • 5.3.1.2.5.2. Research
          • 5.3.1.2.5.3. Diagnostics
          • 5.3.1.2.5.4. Food and Beverages
          • 5.3.1.2.5.5. Soil Treatment
          • 5.3.1.2.5.6. Oil Treatment
          • 5.3.1.2.5.7. Wastewater Treatment
          • 5.3.1.2.5.8. Detergents
          • 5.3.1.2.5.9. Feed
          • 5.3.1.2.5.10. Textile
          • 5.3.1.2.5.11. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Enzymes Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Enzymes Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Enzymes Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Enzymes Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Clinical Trials
  • 17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. BASF SE
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. DuPont de Nemours, Inc.
    • 20.3.3. F. Hoffmann-La Roche Ltd
    • 20.3.4. Novonesis Group (Novozymes A/S)
    • 20.3.5. DSM-Firmenich AG
    • 20.3.6. Lesaffre group
    • 20.3.7. Codexis, Inc.
    • 20.3.8. Advanced Enzyme Technologies Limited
    • 20.3.9. Kerry Group
    • 20.3.10. Amano Enzyme Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer